• Tamoxifen (SKU B5965): Resolving Core Lab Assay Challenges

  2026-06-08

  This article addresses common laboratory challenges in cell viability, proliferation, and CreER-mediated gene knockout assays, showing how Tamoxifen (SKU B5965) from APExBIO delivers reproducible, data-driven solutions. Scenario-based Q&A blocks guide best practices, protocol optimization, and vendor selection for rigorous biomedical research.

• Molnupiravir Protects Mice from Lethal Bourbon Virus Infecti

  2026-06-08

  This study demonstrates that molnupiravir, a broad-spectrum antiviral, significantly inhibits Bourbon virus replication and disease in a lethal mouse model. The findings highlight molnupiravir's potential as a therapeutic candidate for emerging tick-borne RNA virus infections lacking approved treatments.

• Ether Lipid Biosynthesis in B Cells Boosts Antibody Response

  2026-06-07

  Cho et al. (2026) reveal that B cell-intrinsic expression of the PexRAP enzyme, a key intermediary in ether lipid biosynthesis, is crucial for robust antibody responses and germinal center formation. These findings link lipid metabolic pathways directly to humoral immunity, offering new mechanistic insights into the metabolic regulation of B cell function.

• Leptin (116-130), amide, mouse: Novel Pathways in Immunometa

  2026-06-06

  Explore the pleiotropic effects and translational promise of Leptin (116-130), amide, mouse, an adipocyte-derived hormone fragment. This article uniquely bridges immunometabolic signaling and inflammasome research, offering advanced insights for obesity and diabetes studies.

• Fluorescein Tyramide: Amplifying Sensitivity in IHC & ISH As

  2026-06-05

  Fluorescein Tyramide elevates signal detection in low-abundance target assays through robust tyramide signal amplification, transforming workflows in immunohistochemistry and in situ hybridization. Drawing on recent oxytocin pathway research and peer-validated protocols, this article delivers hands-on guidance to optimize sensitivity, troubleshoot artifacts, and achieve reproducible results.

• Dasatinib (BMS-354825): Applied Protocols for Kinase-Driven

  2026-06-05

  Dasatinib (BMS-354825) empowers cancer researchers to dissect Src and Bcr-Abl kinase signaling with exceptional potency and flexibility. This guide delivers actionable, evidence-driven workflows and troubleshooting strategies for advanced studies in EMT, cancer stemness, and metastatic processes.

• AMPK’s Dual Role in Autophagy Revealed: Insights into ULK1 R

  2026-06-04

  This study overturns the prevailing model by showing that AMPK suppresses, rather than induces, autophagy via inhibition of ULK1. The findings refine our understanding of energy stress responses and provide a more nuanced framework for targeting autophagy in disease models.

• Actinomycin D (A4448): Benchmark Transcriptional Inhibitor

  2026-06-04

  Actinomycin D (ActD) is a potent transcriptional inhibitor widely used in cancer research and molecular biology. Its ability to intercalate DNA and block RNA polymerase enables precise dissection of gene regulation and apoptosis induction. This article summarizes mechanisms, evidence, and protocol best practices for reliable deployment in transcriptional stress and DNA damage response assays.

• Remdesivir (GS-5734): Strategic Insights for Translational V

  2026-06-03

  This thought-leadership article provides translational researchers with a mechanistic and strategic perspective on Remdesivir (GS-5734), highlighting its validated antiviral mechanism, experimental benchmarks, and guidance for advancing coronavirus and Ebola virus antiviral research. Integrating recent comparative findings and expert workflows, the piece advances beyond standard product pages to address evolving challenges in RNA virus translational science.

• KN-62: Precision CaMKII Inhibition in Calcium Signaling Assa

  2026-06-03

  KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, is a benchmark tool for dissecting CaMKII-mediated calcium signaling and cell cycle control. This article equips researchers with evidence-backed experimental workflows, advanced applications, and troubleshooting guidance to maximize the selective power of KN-62 in metabolic, cancer, and secretion studies.

• Gramine as a Precision Ferroptosis Tool: Mechanistic Advance

  2026-06-02

  Explore the advanced mechanistic role of Gramine in inducing ferroptosis via CUL3-mediated MTDH ubiquitination. This article delivers unique assay guidance and translational insight, positioning Gramine as a cornerstone for cancer biology research.

• FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone): R

  2026-06-02

  This article delivers scenario-driven guidance for deploying FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone, SKU B5004) in mitochondrial biology and metabolic regulation studies. Drawing on literature and practical lab experience, it addresses experimental design, protocol optimization, and vendor reliability—highlighting FCCP’s reproducibility, solubility, and data-backed performance for cell viability and HIF pathway assays.

• PINK1 Deficiency Drives Mitochondrial Iron Overload in Colon

  2026-06-01

  This study demonstrates that loss of PINK1, a key mitophagy regulator, leads to mitochondrial iron accumulation and promotes colon tumorigenesis. Targeting mitochondrial iron homeostasis emerges as a promising therapeutic avenue for colorectal cancer, particularly in the context of low PINK1 expression.

• Tubastatin A: HDAC6 Inhibitor Redefining Epigenetic Modulati

  2026-06-01

  Explore how Tubastatin A, a potent HDAC6 inhibitor, advances research in epigenetic regulation, neuroprotection, and inflammation. This in-depth analysis reveals unique mechanistic insights and translational potential beyond conventional cardiac and cancer models.

• Remdesivir (GS-5734): Precision Antiviral Design in Emerging

  2026-05-31

  Explore how Remdesivir (GS-5734) empowers antiviral research with unique precision against RNA viruses. This in-depth analysis reveals the mechanistic innovations, protocol guidance, and comparative insights that set it apart for coronavirus and Ebola virus studies.

16034 records 1/1069 page Next 12345 下5页 Last page